Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Developing a CAR-T therapy for children with myelodysplastic syndrome (MDS)
Dr Ghorashian wants to use CAR-T therapy to develop a safer and more effective way to treat children with MDS who are at risk of their cancer developing into AML.
Creating a new way to identify alterations that cause acute lymphoblastic leukaemia (ALL) in children
tba
Using T-cells to understand the risk of getting very sick from covid
Dr Sean Lim and team are comparing two new tests to see how well they work and if they can predict who is more likely to get seriously ill from covid.
Understanding more about the causes of myeloma so new screening tools and drugs can be developed
Professor Chris Bunce wants to understand more about the root causes of myeloma so people at an increased risk of this disease can be screened and monitored and new drugs developed.
Understanding key molecules that help myeloma cells to grow in number and thrive
Professor Karadimitris and his team want to understand more about a specific molecule that can cause people with MGUS to go on to develop myeloma.
Unlocking a new, less harmful way of treating acute myeloid leukaemia (AML)
Professor Lacaud's research is looking to understand more about the KAT6A protein and how it could be used as a kinder treatment for acute myeloid leukaemia (AML).
Developing a more effective CAR-T therapy to treat myeloma
Dr Maciocia is conducting experiments to discover the small proteins that will make CAR-T cells survive longer in people with myeloma.
Identifying the tiny cells that causes AML to evade detection and survive
Professor Tonks plans to investigate a new method that could help ensure all AML cancer cells are destroyed so the cancer is unable to come back.
Developing new drug treatments for mastocytosis
Professor Nerlov wants to develop a new drug that can effectively target and treat mastocytosis.
Developing a new way to treat T-cell acute lymphoblastic leukaemia (T-ALL)
Researchers are developing a kinder, targeted treatment for T‑cell acute lymphoblastic leukaemia to improve survival and quality of life.
Investigating the role of the KCNJ2 gene in chronic myelomoncytic leukaemia (CMML) cancer cells
Dr Batta, University of Manchester, is researching the role of a specific gene called KCNJ2 and how it causes CMML cancer cells to grow.
Finding new, and kinder treatments for diffuse large-B cell lymphoma
Research is looking to understand which people with diffuse large-B cell lymphoma might benefit from a new drug.
Finding a new way to treat leukaemia
Professor Kent and his team are testing a new tool to study differences between healthy and cancerous blood cells, with the aim of developing new leukaemia treatments.
Finding new ways to treat acute myeloid leukaemia
This project aims to find new ways to treat acute myeloid leukaemia, a blood cancer that is difficult to treat.
Understanding how plasma cells become cancerous in myeloma
In this research project Professor Tooze hopes to understand more about how plasma cells become cancerous.
Understanding how we could make better drug treatments to target acute myeloid leukaemia (AML)
Dr Payne wants to understand more about a specific alteration that causes acute myeloid leukaemia (AML), to help develop new, more effective drug treatments with fewer side effects.
Combining drugs to create a new treatment for follicular lymphoma
Dr Riches is testing new drug combinations to improve treatment for follicular lymphoma, a blood cancer that remains treatable but not curable.
Understanding the molecules that help myeloma cells to grow and survive
Dr Karadimitris wants to understand more about how myeloma cells grow and survive so he can design and develop a new treatment for people with myeloma.
Using AI techniques to improve the diagnosis of myeloproliferative neoplasms (MPN)
In this project, Dr Royston is researching the use of computerised techniques to help to diagnose myeloproliferative neoplasms (MPN).
Using data to understand more about blood cancer
In this project Professor Pettitt will look at data on 700,000 people affected by blood cancer to understand more about the disease.
Finding new ways to identify and treat the most aggressive type of DLBCL
Dr Calado is working to understand more about why some types of DLBCL stop responding to treatment.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.